Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	79.81	51.37	31.17	73.98	50.71	71.72
Short-Term Investments	11.76	22.41	73.94	22.52	106.51	149.68
Cash & Short-Term Investments	91.58	73.78	105.11	96.5	157.22	221.4
Cash Growth	39.16%	-29.81%	8.92%	-38.62%	-28.99%	245.09%
Accounts Receivable	42.44	34.1	12.1	-	-	-
Other Receivables	-	-	-	2.25	2.44	3.33
Total Trade Receivables	42.44	34.1	12.1	2.25	2.44	3.33
Inventory	23.91	20.3	10.38	-	-	-
Other Current Assets	14.3	6.04	6.61	2.1	32.83	38.73
Total Current Assets	172.23	134.21	134.2	100.84	192.49	263.45
Net Property, Plant & Equipment	3.01	2.16	3.18	2.55	2.94	2.96
Goodwill	16.84	16.84	16.84	16.84	16.84	16.84
Other Long-Term Assets	7.38	11.04	10.48	12.55	35	28.38
Total Assets	199.45	164.24	164.7	132.79	247.27	311.64

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	12.58	7.33	11.43	7.89	7.68	2.93
Accrued Expenses	44.16	40.65	24.23	7.33	7.15	6.5
Current Portion of Long-Term Debt	-	-	-	37.67	-	-
Current Portion of Leases	0.74	0.58	0.93	0.96	0.9	0.47
Other Current Liabilities	5.01	0.27	0.26	1.94	5.27	5.2
Total Current Liabilities	62.49	48.83	36.86	55.79	21	15.11
Long-Term Debt	-	-	-	91.61	142.4	128.21
Long-Term Leases	1.81	1.12	1.69	0.78	1.71	1.84
Other Long-Term Liabilities	36.93	40.43	38.41	5.74	3.92	4.21
Total Long-Term Liabilities	38.74	41.55	40.1	98.14	148.02	134.26
Total Liabilities	101.22	90.39	76.96	153.93	169.02	149.37

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Preferred Stock	-	-	0.05	0.01	0.01	0.01
Common Stock	0.97	0.97	0.9	0.63	0.59	0.58
Additional Paid-in Capital	910.39	891.79	855.45	589.78	549.35	566.92
Accumulated Other Comprehensive Income	-23.58	-24.58	-23.17	-26.34	-23.94	-21.05
Retained Earnings	-789.56	-794.33	-745.5	-585.22	-447.76	-384.19
Shareholders' Equity	98.23	73.85	87.74	-21.15	78.24	162.27
Total Liabilities & Equity	199.45	164.24	164.7	132.79	247.27	311.64

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	2.55	1.7	2.62	131.02	145	130.52
Net Cash (Debt)	89.03	72.07	102.49	-34.52	12.22	90.88
Net Cash Growth	39.40%	-29.68%	-	-	-86.56%	-
Net Cash Per Share	0.91	0.76	1.28	-0.57	0.21	1.65
Book Value	98.23	73.85	87.74	-21.15	78.24	162.27
Book Value Per Share	1.00	0.78	1.09	-0.35	1.34	2.95
Tangible Book Value	81.39	57.01	70.9	-37.98	61.41	145.43
Tangible Book Value Per Share	0.83	0.60	0.88	-0.63	1.05	2.65

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Sep 30, 2025

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error